Loading…
Amazon.com distributed seven unapproved ophthalmic drug products through its website and Fulfillment by Amazon service, including Similasan Pink Eye Relief, The Goodbye Company Pink Eye, Can-C Eye Drops, Optique 1 Eye Drops, OcluMed Eye Drops, TRP Natural Eyes Floaters Relief, and Manzanilla Sophia Chamomile Herbal Eye Drops, in violation of sections 301(d) and 505(a) of the Federal Food, Drug, and Cosmetic Act. The products were classified as unapproved new drugs because they were intended for use in diagnosing, curing, mitigating, treating, or preventing disease. The FDA emphasized that eye drops pose particular public health concerns due to their route of administration directly into the eyes, which bypasses the body's natural defenses.